Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Messing

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Cancer|July 2, 2011
Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladderEmil Scosyrev, Edward M Messing, Edwin van Wijngaarden, et al.
The Journal of Urology|January 23, 2013
The management of a clinical t1b renal tumor in the presence of a normal contralateral kidneyChristopher J Weight, David C Miller, Steven C Campbell, et al.
International Journal of Molecular Sciences|March 25, 2022
Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor ImmunityCarlos J Ortiz-Bonilla, Taylor P Uccello, Scott A Gerber, et al.
Endocrinology|August 30, 2008
Defects of prostate development and reproductive system in the estrogen receptor-alpha null male miceMing Chen, Iawen Hsu, Andrew Wolfe, et al.
Urology Practice|June 10, 2023
Antibiogram Directed Prophylaxis for Transrectal Prostate Biopsy: An Application of Recommendations in the Setting of High Fluoroquinolone Escherichia coli ResistanceYifan Meng, Jimena Cubillos, Marianne Borch, et al.
BMC Urology|April 25, 2008
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1Aimee M Johnson, Mary J O'Connell, Hiroshi Miyamoto, et al.
Urology Practice|August 18, 2023
Cost-Effectiveness of Extended Duration Venous Thromboembolism Prophylaxis in High Risk Urological Oncology Surgical PatientsJanet E Baack Kukreja, Helen R Levey, Ahmed Ghazi, et al.
Plos One|May 18, 2016
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder CancerElizabeth A Guancial, Deepak Kilari, Guang-Qian Xiao, et al.
Journal of Biomedical Optics|October 23, 2012
Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidneyTimothy M Baran, Jeremy D Wilson, Soumya Mitra, et al.
BMC Cancer|August 7, 2021
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patientsNerymar Ortiz-Otero, Jocelyn R Marshall, Antonio Glenn, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Cancer|July 2, 2011
Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladderEmil Scosyrev, Edward M Messing, Edwin van Wijngaarden, et al.
The Journal of Urology|January 23, 2013
The management of a clinical t1b renal tumor in the presence of a normal contralateral kidneyChristopher J Weight, David C Miller, Steven C Campbell, et al.
International Journal of Molecular Sciences|March 25, 2022
Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor ImmunityCarlos J Ortiz-Bonilla, Taylor P Uccello, Scott A Gerber, et al.
Endocrinology|August 30, 2008
Defects of prostate development and reproductive system in the estrogen receptor-alpha null male miceMing Chen, Iawen Hsu, Andrew Wolfe, et al.
Urology Practice|June 10, 2023
Antibiogram Directed Prophylaxis for Transrectal Prostate Biopsy: An Application of Recommendations in the Setting of High Fluoroquinolone Escherichia coli ResistanceYifan Meng, Jimena Cubillos, Marianne Borch, et al.
BMC Urology|April 25, 2008
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1Aimee M Johnson, Mary J O'Connell, Hiroshi Miyamoto, et al.
Urology Practice|August 18, 2023
Cost-Effectiveness of Extended Duration Venous Thromboembolism Prophylaxis in High Risk Urological Oncology Surgical PatientsJanet E Baack Kukreja, Helen R Levey, Ahmed Ghazi, et al.
Plos One|May 18, 2016
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder CancerElizabeth A Guancial, Deepak Kilari, Guang-Qian Xiao, et al.
Journal of Biomedical Optics|October 23, 2012
Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidneyTimothy M Baran, Jeremy D Wilson, Soumya Mitra, et al.
BMC Cancer|August 7, 2021
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patientsNerymar Ortiz-Otero, Jocelyn R Marshall, Antonio Glenn, et al.
Pageof 20